 Connection
Paul Bunn to Doxorubicin
This is a "connection" page, showing publications Paul Bunn has written about Doxorubicin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.204 |
|
|
|
-
Chan DC, Gera L, Stewart JM, Helfrich B, Zhao TL, Feng WY, Chan KK, Covey JM, Bunn PA. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents. Clin Cancer Res. 2002 May; 8(5):1280-7.
Score: 0.045
-
Bunn PA. Editorial comments on 'Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'. Ann Oncol. 2001 Oct; 12(10):1339-40.
Score: 0.044
-
Bunn P, Arriagada R, Choi N, Feld R, Gregor A, Jett J, Johnson B, Komaki R, Kristjansen P, Murray N, et al. Combined modality therapy in small cell lung cancer. Lung Cancer. 1994 Mar; 10 Suppl 1:S25-8.
Score: 0.026
-
Bunn PA, Greco FA, Einhorn L. Cyclophosphamide, doxorubicin, and etoposide as first-line therapy in the treatment of small-cell lung cancer. Semin Oncol. 1986 Sep; 13(3 Suppl 3):45-53.
Score: 0.015
-
Morstyn G, Schechter GP, Ihde DC, Carney DN, Eddy JL, Cohen MH, Minna JD, Bunn PA. Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness. Cancer Treat Rep. 1984 Dec; 68(12):1439-46.
Score: 0.014
-
Ihde DC, Bunn PA, Cohen MH, Dunnick NR, Eddy JL, Minna JD. Effective treatment of hormonally-unresponsive metastatic carcinoma of the prostate with adriamycin and cyclophosphamide: methods of documenting tumor response and progression. Cancer. 1980 Mar 15; 45(6):1300-10.
Score: 0.010
-
Mulvin DW, Howard RB, Mitchell DH, Noker PE, Kruse CA, Chu HD, Bunn PA, Johnston MR. Secondary screening system for preclinical testing of human lung cancer therapies. J Natl Cancer Inst. 1992 Jan 01; 84(1):31-7.
Score: 0.006
-
Kaye FJ, Bunn PA, Steinberg SM, Stocker JL, Ihde DC, Fischmann AB, Glatstein EJ, Schechter GP, Phelps RM, Foss FM, et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med. 1989 Dec 28; 321(26):1784-90.
Score: 0.005
-
Ihde DC, Deisseroth AB, Lichter AS, Bunn PA, Carney DN, Cohen MH, Veach SR, Makuch RW, Johnston-Early A, Abrams RA, et al. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer. J Clin Oncol. 1986 Oct; 4(10):1443-54.
Score: 0.004
-
Seifter EJ, Bunn PA, Cohen MH, Makuch RW, Dunnick NR, Javadpour N, Bensimon H, Eddy JL, Minna JD, Ihde DC. A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostate. J Clin Oncol. 1986 Sep; 4(9):1365-73.
Score: 0.004
-
Brooks BJ, Seifter EJ, Walsh TE, Lichter AS, Bunn PA, Zabell A, Johnston-Early A, Edison M, Makuch RW, Cohen MH, et al. Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer. J Clin Oncol. 1986 Feb; 4(2):200-9.
Score: 0.004
-
Lichter AS, Bunn PA, Ihde DC, Cohen MH, Makuch RW, Carney DN, Johnston-Early A, Minna JD, Glatstein E. The role of radiation therapy in the treatment of small cell lung cancer. Cancer. 1985 May 01; 55(9 Suppl):2163-75.
Score: 0.003
-
Doyle LA, Ihde DC, Carney DN, Bunn PA, Cohen MH, Matthews MJ, Puffenbarger R, Cordes RS, Minna JD. Combination chemotherapy with doxorubicin and mitomycin C in non-small cell bronchogenic carcinoma. Severe pulmonary toxicity from q 3 weekly mitomycin C. Am J Clin Oncol. 1984 Dec; 7(6):719-24.
Score: 0.003
-
Brower M, Ihde DC, Johnston-Early A, Bunn PA, Cohen MH, Carney DN, Makuch RW, Matthews MJ, Radice PA, Minna JD. Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy. Am J Med. 1983 Dec; 75(6):993-1000.
Score: 0.003
-
Morstyn G, Ihde DC, Eddy JL, Bunn PA, Cohen MH, Minna JD. Combination chemotherapy of hepatocellular carcinoma with doxorubicin and streptozotocin. Am J Clin Oncol. 1983 Oct; 6(5):547-51.
Score: 0.003
-
Radice PA, Matthews MJ, Ihde DC, Gazdar AF, Carney DN, Bunn PA, Cohen MH, Fossieck BE, Makuch RW, Minna JD. The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes. Cancer. 1982 Dec 15; 50(12):2894-902.
Score: 0.003
-
Thant M, Hawley RJ, Smith MT, Cohen MH, Minna JD, Bunn PA, Ihde DC, West W, Matthews MJ. Possible enhancement of vincristine neuropathy by VP-16. Cancer. 1982 Mar 01; 49(5):859-64.
Score: 0.003
-
Johnston-Early A, Cohen MH, Minna JD, Paxton LM, Fossieck BE, Ihde DC, Bunn PA, Matthews MJ, Makuch R. Smoking abstinence and small cell lung cancer survival. An association. JAMA. 1980 Nov 14; 244(19):2175-9.
Score: 0.003
-
Shackney SE, Bunn PA, Ford SS, Erickson B, Ross WE, Levine AS. A study of drug-induced kinetic perturbations in the marrow of a patient with neuroblastoma. Cancer. 1980 Mar 01; 45(5):882-92.
Score: 0.002
-
Cohen MH, Chretien PB, Ihde DC, Fossieck BE, Makuch R, Bunn PA, Johnston AV, Shackney SE, Matthews MJ, Lipson SD, Kenady DE, Minna JD. Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer. JAMA. 1979 Apr 27; 241(17):1813-5.
Score: 0.002
-
Cohen MH, Ihde DC, Bunn PA, Fossieck BE, Matthews MJ, Shackney SE, Johnston-Early A, Makuch R, Minna JD. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma. Cancer Treat Rep. 1979 Feb; 63(2):163-70.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|